Bob Lederer RFL Communications, Inc.

Pharma MR Groups That Participate The Most / RBDR

Do you regularly watch RBDR? Do you find it informative and entertaining? Help maintain and continue our video based on what you can afford and believe we deserve (e.g., $5 or $10 for an individual, perhaps $25 to $50 from a business per month). Visit Patreon.com/RBDR.

———————————————————————————-

January 4, 2023

Today on RBDR: Rare Patient Voice President Wes Michael explains why the sampling firm decided to aggregate and publicize the groups of physicians who most participate in pharmaceutical market research.

No need to spend time searching for today’s RBDR video. Subscribe to receive a FREE, personal email as soon as the latest RBDR is uploaded. Click here: http://ow.ly/CfFWE

Bob Lederer RBDR

Nielsen pushes new TV/digital measurement. Pharma companies’ high ad spending means low drug development. (RBDR 01.12.2016)

Today on RBDR:

1) At the 2016 Consumer Electronics Show, Nielsen pushed the need for a new, common viewing measurement for TV and digital devices.

2) A University of North Carolina Charlotte study shows pharmaceutical companies that spend the most on advertising also spend the least on new drug development. This is likely bad news for the image of the pharmaceutical industry.

RBDR is sponsored by Socratic Technologies, whose proprietary tools and methodologies tackle marketing complexities so that you can make more confident business decisions. Visit sotech.com.

Don’t spend your time “searching” for today’s RBDR video. Subscribe to receive a personal email as soon as the new RBDR is uploaded. Click here.